Voyager Life PLC Board Change (2091S)

TIDMVOY

RNS Number : 2091S

Voyager Life PLC

08 March 2023

8 March 2023

Voyager Life plc

("Voyager" or the "Company")

Board Change

Voyager, the health and wellness company manufacturing and supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, announces that Nikki Cooper, a non-executive director, will be leaving the Board on 31 March 2023.

Mrs Cooper has recently accepted an offer of a new full time role that prevents her from holding outside interests and so has notified the Board of her resignation and intention to leave on that date .

Eric Boyle, Chairman of Voyager, said: "Nikki has been an active and supportive member of our board since our IPO in 2021, offering sound advice as Voyager has grown since then into the business it is today. On behalf of the Board and all of the Voyager team, I thank her for all that she has done for us and we wish her well in her new role."

The Directors of the Company are responsible for the release of this announcement.

ENDS

Enquiries:

 
 Voyager Life plc                          Tel: [phone] 
                                            693 
  Nick Tulloch, CEO 
                                            http://voyagerlife.uk 
                                            [e-mail] 
 Cairn Financial Advisers LLP (AQSE        Tel: [phone] 
  Corporate Adviser)                        0880 
 
  Ludovico Lazzaretti/Liam Murray 
 Stanford Capital Partners LLP (Broker) 
 
  Patrick Claridge                           [phone] 
 
  Bob Pountney                               [phone] 
 
  John Howes                                 [phone] 
 

Notes to Editors:

About Voyager

Voyager was founded in 2020 and is based in Perth, Scotland. The Company's primary objective is the formulation and supply of high quality CBD and hemp seed oil products although it also produces several other complementary products, the majority of which are manufactured from the hemp plant. Its product categories include a pet range which has rapidly developed into one of the Company's best sellers. The Company sells online, through third party stores and in its own stores which are located in St Andrews, Edinburgh and Dundee. The Company has two principal retail brands: Voyager, focused on health & wellness, and Ascend Skincare, its beauty range. Voyager products are currently available from Cornwall to Shetland in over 150 online and brick-and-mortar outlets. In December 2022, with the aim of expanding its manufacturing capability for EU markets, Voyager purchased a state-of-the-art CBD extraction and manufacturing facility in Poland.

The Company's philosophy of plant-based health and wellness is embodied in its mission statement and hashtag of "Choose you". With an experienced team and a product line created in line with the UK's regulatory regime, Voyager aims to become the trusted brand in this increasingly popular health and wellness space.

Through Voyager's bespoke skincare product creation and development division , voyagerCann , the Company also offers a full turnkey service to other CBD, skincare and cosmetics brands assisting them in developing and launching new products with manufacturing and distribution facilities in Scotland and Poland.

Website and social media links:

Voyager:

https://voyagercbd.com/

https://www.instagram.com/voyagercbd/

https://twitter.com/voyagercbd

https://www.linkedin.com/company/voyager-cbd/

https://www.facebook.com/voyagercbd/

voyagerCann:

https://voyagercann.com/

https://www.instagram.com/voyagercann/

https://twitter.com/voyagercann/

https://www.linkedin.com/company/voyagercann/

https://www.facebook.com/voyagercann/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXUPUAAWUPWGMM

(END) Dow Jones Newswires

March 08, 2023 02:00 ET (07:00 GMT)